Brittney Sawyer
Acute Care · Pasadena, TXNPI 1972140341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $36.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$533
- AbbVie$413
- Boston Scientific$290
- Viiv Healthcare Company$237
- Shionogi Inc$234
- Merck$227
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,346100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 4 | $533 |
| AbbVie | 20 | $413 |
| Boston Scientific | 2 | $290 |
| Viiv Healthcare Company | 10 | $237 |
| Shionogi Inc | 9 | $234 |
| Merck | 12 | $227 |
| Revance Therapeutics, Inc. | 2 | $201 |
| Endologix LLC | 2 | $165 |
| Abiomed | 1 | $140 |
| Penumbra, Inc. | 1 | $138 |
| Abbott | 1 | $136 |
| Johnson & Johnson | 2 | $136 |
| Gilead | 7 | $126 |
| Cumberland Pharmaceuticals, Inc. | 5 | $97 |
| Relievant Medsystems, Inc. | 5 | $83 |
| EMD Serono, Inc. | 2 | $58 |
| La Jolla Pharmaceutical Company | 2 | $49 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
| Merz North America, Inc. | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,346 in reported general payments places this provider in the 90th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methenamine Hippurate | 11 | $711 |
Paid to pharmacies, not to this prescriber.
Other acute care in Pasadena
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Bahia ElkamandSugar Land$23K
- Rachael SchneiderDallas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.